All In MedTech

FDA Clearance Tracker · P890055-S013

MODEL 3000 SERIES IMPLANTABLE INFUSION PUMPS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 18, 2002 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 18, 2002

Approved

Time to decision

499 days

Received Jun 6, 2001. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P890055-S013
Device name
MODEL 3000 SERIES IMPLANTABLE INFUSION PUMPS
Applicant location
Newton, MA
Received
Jun 6, 2001
Decided
Oct 18, 2002
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P890055

Device type

Device class
Class III

Every decision under product code LKK

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE INDICATIONS FOR USE TO INCLUDE GLYCERIN INJECTION AS AN INFUSATE FOR USE WITH PATIENTS WHO ARE RECEIVING CONTINUOUS HEPATIC ARTERIAL FUDR CHEMOTHERAPY WITH THE ARROW INTERNATIONAL MODEL 3000 SERIES OF IMPLANTABLE INFUSION PUMPS TO KEEP THE CATHETER PATENT OR TO EXTEND THE REFILL INTERVAL FOR PATIENTS WHO REQUIRE THERAPY OR WITHDRAWAL.

Source documents

Other decisions for Intera Oncology

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.